[Kaposi sarcoma in cyclosporin A therapy of actinic reticuloid]

Hautarzt. 1997 Apr;48(4):262-5. doi: 10.1007/s001050050581.
[Article in German]

Abstract

A 76 year old patient with actinic reticuloid was treated with Cyclosporin A. 11 months after beginning the immunosuppressive therapy, he developed lymphoedema and livid nodular skin lesions of the right leg, which histologically showed Kaposi's sarcoma. After stopping the Cyclosporin A and intralesional therapy with Interferon alpha, no regression of the Kaposi sarcoma could be seen. The characteristics of Kaposi sarcoma arising during immunosuppressive therapy and the differences in incidence, risk groups and distribution pattern compared to the classic sporadic and the AIDS-related Kaposi sarcoma will be described. The development of Kaposi sarcoma during immunosuppressive therapy for actinic reticuloid has not been previously described.

Publication types

  • Case Reports
  • English Abstract

MeSH terms

  • Aged
  • Cell Transformation, Neoplastic / chemically induced
  • Cell Transformation, Neoplastic / pathology
  • Cyclosporine / adverse effects*
  • Cyclosporine / therapeutic use
  • Humans
  • Immunosuppressive Agents / adverse effects*
  • Immunosuppressive Agents / therapeutic use
  • Male
  • Photosensitivity Disorders / drug therapy*
  • Photosensitivity Disorders / pathology
  • Risk Factors
  • Sarcoma, Kaposi / chemically induced*
  • Sarcoma, Kaposi / pathology
  • Skin / pathology
  • Skin Neoplasms / chemically induced*
  • Skin Neoplasms / pathology

Substances

  • Immunosuppressive Agents
  • Cyclosporine